Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1088/1361-6498/ab2d92 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Resilience: Now What? Comment on "Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons From the First Two Years of the Pandemic".
Int J Health Policy Manag
December 2024
Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland.
In this paper we draw upon the review article "Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons from the First Two Years of the Pandemic" by Saulnier et al to propose some additional themes to be considered regarding ongoing conversations on health system resilience. Complementing the lessons learned brought forward in the article, we propose three thematic areas which may enrichen this conversation. These three themes are posed as questions: (1) Transformation - towards what? (2) Crises and shocks - what counts as such? and (3) Levels and scales - can tensions be reconciled? While our insights are strongly rooted in research results on health system resilience during COVID-19 in Finland, we seek to discuss their wider implications for health system resilience and beyond the context of a single country.
View Article and Find Full Text PDFPolitical Prioritization of Access to Medicines and Right to Health: Need for an Effective Global Health Governance Through Global Health Diplomacy Comment on "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry's Role in Widening the Access Gap".
Int J Health Policy Manag
December 2024
Center for Evidence-based Diplomacy, Global Health Research and Innovations Canada Inc. (GHRIC), Toronto, ON, Canada.
Borges and colleagues' article entitled "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry's Role in Widening the Access Gap," analyzes the role of pharmaceutical companies in providing equitable access to COVID-19 vaccines. They concluded that with the failure of COVID-19 Vaccine Global Access (COVAX), the health gaps have widened due to the profit-driven pharmaceutical sector. In this commentary, we highlight the role of COVAX and its attempt to bridge some access gaps since its inception and the need for reforms in policy-making and global health governance.
View Article and Find Full Text PDFCan't Contracting Be Relational? Comment on "Alignment in the Hospital-Physician Relationship: A Qualitative Multiple Case Study of Medical Specialist Enterprises in the Netherlands".
Int J Health Policy Manag
December 2024
Faculty of Medicine, Health and Life Science, Swansea University, Swansea, UK.
Ubels and van Raaij provide a valuable account of the operation of novel hospital/medical specialist enterprise (MSE) contracts in a Dutch healthcare system shaped by market reform. However, their analytical distinction between the separate domains of contractual and relational governance frames the contractual domain more narrowly than does the relational contract theory widely deployed in socio-legal studies. The authors' conclusion that contract plays little or no part in governing relations between hospitals and MSEs leads them to underplay a wider realm of contractual practices that develop in the shadow of the written contract.
View Article and Find Full Text PDFThreats to Women's Health in Prisons and Jails.
JAMA Intern Med
January 2025
Department of Medicine, University of California San Francisco.
Medicaid Accountable Care Organizations and Disparities in Pediatric Asthma Care.
JAMA Pediatr
November 2024
Department of Health Promotion and Policy, School of Public Health & Health Sciences, University of Massachusetts Amherst.
Article Synopsis
- - Nearly 6 million children in the US have asthma, with over a third covered by Medicaid; despite experiments with accountable care organizations (ACOs) in 23 state Medicaid programs, their impact on asthma care and outcomes is not well understood.
- - The study aimed to evaluate the effects of Massachusetts Medicaid ACO implementation in March 2018 on the quality of asthma care and healthcare use among children aged 2 to 17, using data from 2014 to 2020.
- - Results showed no significant change in routine asthma visit rates for Medicaid-insured children compared to privately insured ones after ACO implementation, though an increase in the proportion of Medicaid-insured children with a favorable asthma medication ratio was noted. *
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!